Dorling, L.,
Carvalho, S.,
Allen, J.,
González-Neira, A.,
Luccarini, C.,
Wahlström, C.,
Pooley, K.A.,
Parsons, M.T.,
Fortuno, C.,
Wang, Q.,
Bolla, M.K.,
Dennis, J.,
Bermisheva, M.,
Khusnutdinova, E.,
Prokofyeva, D.,
other additional authors (2021) BACKGROUND Genetic testing for breast
cancer susceptibility is widely used, but for many genes
Pang, H.Y.,
Chen, X.L.,
Song, X.H.,
Galiullin, D.,
Zhao, L.Y.,
Liu, K,
Zhang, W.H.,
Yang, K,
Chen, X.Z.,
Hu, J.K. (2021) (ICGFA) to prevent anastomotic leakage (AL) in rectal
cancer surgery remains controversial. Methods
Пути развития иммунотерапии колоректального ракаIn colorectal
cancer immunotherapy, the use of antibodies against the PD-1/PD-L1 checkpoints showed
Mingazheva, E.T.,
Prokofyeva, D.S.,
Valova, Ya.V.,
Andreeva, E.A.,
Nurgalieva, A.Kh.,
Valiev, R.R.,
Ekomasova, N.V.,
Faishanova, R.R.,
Romanova, A.R.,
Khusnutdinova, E.K. (2022) The high risk of ovarian
cancer is primarily associated with mutations in BRCA1 and BRCA2 genes